Creo Medical Group PLC (AIM:CREO)
London · Delayed Price · Currency is GBP · Price in GBX 14.00
-0.13 (-0.88%)
Mar 5, 2026, 3:54 PM GMT
Creo Medical Group Market Cap
Creo Medical Group has a market cap or net worth of 56.85 million as of March 5, 2026. Its market cap has decreased by -12.54% in one year.
Market Cap
56.85M
Enterprise Value
40.55M
Revenue
4.60M
Ranking
n/a
PE Ratio
64.06
Stock Price
14.00
Market Cap Chart
Since December 9, 2016, Creo Medical Group's market cap has decreased from 64.46M to 56.85M, a decrease of -11.80%. That is a compound annual growth rate of -1.35%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Mar 4, 2026 | 56.85M | 42.68% |
| Dec 31, 2025 | 39.84M | -49.19% |
| Dec 31, 2024 | 78.42M | -51.05% |
| Dec 29, 2023 | 160.20M | 255.34% |
| Dec 30, 2022 | 45.08M | -83.01% |
| Dec 31, 2021 | 265.37M | -13.37% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
| Dec 9, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| AstraZeneca | 234.01B |
| GSK plc | 83.22B |
| Haleon | 34.46B |
| Smith & Nephew | 11.35B |
| ECO Animal Health Group | 67.76M |
| Faron Pharmaceuticals Oy | 67.15M |
| Hemogenyx Pharmaceuticals | 60.33M |
| hVIVO | 57.15M |